VLDL apo B-100 is essential for the secretion of liver fat. It is thought that synthesis of this lipoprotein is impaired in childhood severe acute malnutrition (SAM), especially in the edematous syndromes, and that this contributes to the common occurrence of hepatic steatosis in this condition. However, to our knowledge, it has not been confirmed that VLDL apo B-100 synthesis is slower in edematous compared with nonedematous SAM and that it is impaired in the malnourished compared with the well-nourished state. Therefore, VLDL apo B-100 kinetics were measured in 2 groups of children with SAM (15 edematous and 7 nonedematous), aged 4-20 mo, at 3 stages during treatment. Measurements were done at 4 6 1 d postadmission, mid-catch-up growth in weight, and at recovery (normal weight-for-length). VLDL apo B-100 synthesis was determined using stable isotope methodology to measure the rate of incorporation of 2 H 3 -leucine into its apoprotein moiety. The fractional and absolute synthesis of VLDL apo B-100 did not differ between the groups or from the initial malnourished stage to the recovery stage. Concentrations of VLDL apo B-100 were greater in the edematous than in the nonedematous group (P , 0.04) and did not differ from the initial stage to recovery. The data indicate that VLDL apo B-100 synthesis is not reduced when children develop either edematous or nonedematous SAM. J. Nutr. 142: 931-935, 2012. 
Introduction
Liver lipid is secreted as VLDL apo B-100, with the major lipid component being TG. It is widely thought that synthesis of this lipoprotein is reduced when children develop severe acute malnutrition (SAM) 5 (1) (2) (3) . This led to the general acceptance that fatty liver in SAM, especially in the edematous syndromes, is a consequence of impaired VLDL apo B-100 synthesis (2) (3) (4) (5) . Based on studies in protein-deficient rats, it was hypothesized that protein deficiency in SAM can similarly lead to reduced rates of synthesis of VLDL apo B-100 in hepatocytes (2) , resulting in impaired removal of TG from the liver. However, VLDL apo B-100 synthesis might not be reduced in SAM, because we recently measured its rate of synthesis in severely malnourished children and found that the synthesis rate was positively correlated with degree of liver fat (6) . This indicates some degree of compensation in VLDL apo B-100 synthesis, but it is still not known if the rate of synthesis is impaired in SAM compared to the well-nourished state and if there is a difference between edematous and nonedematous SAM.
Nonetheless, the possibility exists that there is an upregulation of VLDL apo B-100 synthesis in SAM relative to the wellnourished state that is associated with increased influx of fatty acids to the liver from enhanced lipolysis in both edematous and nonedematous SAM plus lower whole-body fatty acid oxidation in edematous SAM (7) . Also, VLDL apo B-100 synthesis may remain faster during mid-recovery to enhance removal of excess TG, because the rate of fat disappearance from the livers of malnourished children is slow during the early phase of recovery (8) . On the other hand, reducing protein intake to a marginal level in adults resulted in a 20% reduction in VLDL apo B-100 synthesis (9) , which is possible in malnourished children consuming low-protein diets.
Understanding the mechanisms underlying clinical abnormalities in SAM can lead to useful intervention for reducing morbidity and mortality. Case mortality remains high in children with SAM and fatty liver is one factor contributing to poor prognosis in these children (5) . Because VLDL apo B-100 is important in the secretion of liver fat and there is uncertainty about its synthesis rate in malnourished children, we aimed to determine whether the synthesis rate of this lipoprotein is different between edematous and nonedematous SAM and between the malnourished state and the well-nourished state during nutritional rehabilitation. A stable isotope tracer method was used to measure VLDL apo B-100 synthesis.
Methods
Participants. The study consisted of 22 children aged 4-20 mo that were recruited from among patients admitted to the ward of the Tropical Metabolism Research Unit of the University of the West Indies, Jamaica for treatment of primary SAM. The children were diagnosed according to the Wellcome Classification (10) and were studied as 2 groups. The edematous group included children with kwashiorkor or marasmickwashiorkor and the nonedematous group comprised children with marasmus. This study was conducted in accordance with the Helsinki Declaration of 1975 as revised in 1983 for human experimentation. The University Hospital/University of the West Indies Faculty of Medical Sciences Ethics Committee and the Baylor Affiliates Review Board for Human Subject Research, Baylor College of Medicine approved the study. Written informed consent was obtained from a parent or guardian of each enrolled child.
Rehabilitation diet. Dietary treatment was based on a standard rehabilitation regime that takes into consideration the metabolic capacity at different stages of treatment (11,12) using a milk (Bio Nan)-based diet. Treatment started with a resuscitative diet from admission until infection was treated, edema was lost, and there was improvement in electrolyte disturbances, affect, and appetite. During this period, the children were fed a diet ( 21 of iron sulfate was given during the catch-up period only. Over each 24-h period, the children were fed every 3 h during the early phase of treatment followed by 4 hourly feeds.
Study design. Measurements were carried out in each child at 3 stages. First, at 4 6 1 d (mean 6 SEM) postadmission after acute resuscitation and when acutely malnourished, then during catch-up growth when they had replenished 50% of their weight deficit, and finally at the recovery stage when they had attained at least 90% of the appropriate weight for their length. The VLDL apo B-100 rate of synthesis was measured with an i.v. infusion of isotopically labeled leucine. During the measurements, the children were deprived of the usual feeds. To avoid hypoglycemia, they received only a 5% dextrose solution that was i.v. infused at 3 mg × kg 21 × min 21 starting 2 h before starting the isotope infusion. The isotope infusions were performed over a 6-h period, starting 2 h after the last regular bolus meal.
Tracer infusion protocol. The rate of synthesis of VLDL apo B-100 was measured over a 6-h period by i.v. infusion of a sterile solution of 2 H 3 -leucine (Cambridge Isotope Laboratories) and taking blood samples using procedures as we previously described (6). After taking a blood sample for baseline measurements, a 10-mmol × kg 21 priming dose of 2 H 3 -leucine was administered and immediately followed by a continuous infusion at 10 mmol × kg 21 × h 21 for 6 h. Additional 1-mL blood samples were drawn hourly during the infusion.
Sample collection and analysis. The blood samples were collected in prechilled tubes containing Na 2 EDTA and a cocktail of sodium azide, merthiolate, and soybean trypsin inhibitor. They were immediately centrifuged at 1000 3 g for 15 min at 48C and the plasma removed and stored at 2708C for later analyses. VLDL were isolated from plasma by ultracentrifugation as previously described by us (6), its apo B-l00 precipitated, isolated, and acid hydrolyzed to amino acids that were converted to the n-propyl ester heptaflourobutyramide derivatives. The isotopic enrichment of derivatized leucine was measured by GC-MS (6) . Briefly, the leucine isotope ratio was measured by monitoring ions at m/z 349-352 on a Hewlett-Packard 5988A Gas Chromatography Mass Spectrometer. The VLDL apo B-l00 concentration was measured by radial immunodiffusion on an aliquot of the supernatant.
Calculations. The fractional synthesis rate (FSR) of VLDL apo B-100 was calculated from the rate of incorporation of 2 H 3 -leucine into the protein moiety during the rise to a plateau and the isotopic enrichment of the protein at plateau as described by us (6) .
where IE t2 2 IE t1 is the rate of increase in isotopic enrichment of apo B-100-bound leucine from time t 1 to t 2 hours during the rise to a plateau and IE pl is the isotopic enrichment of apo B-100-bound leucine at plateau. A nonlinear curve fit was performed with GraphPad Prism version 3 software (GraphPad Software) using a 1-phase exponential equation. This method uses the apo B-100-bound leucine isotopic enrichment points that fell on the linear section of the curve during the rise to an implicit plateau to calculate the rate of incorporation of the tracer into the protein. Plateau isotopic enrichment of apo B-100-bound leucine, which was achieved in all the studies, was assumed to represent the isotopic enrichment of the intrahepatic leucine pool (precursor pool) from which the VLDL apo B-l00 is synthesized (13) . The intravascular absolute synthesis rate of VLDL apo B-l00 was estimated as the product of the FSR and the intravascular VLDL apo Bl00 mass, where the intravascular VLDL apo B-l00 mass is the product of the plasma volume, specific for diagnosis, and the plasma concentration of VLDL apo B-l00. The plasma volume was based on measurements that we conducted in a group of malnourished children at a similar stage of rehabilitation using Evan's blue dilution. The mean estimates of plasma volume obtained were: kwashiorkor, 65 mL × kg 21 (n = 14); marasmic kwashiorkor, 76.9 mL × kg 21 (n = 10); and marasmus, 75.8 mL × kg 21 (n = 9). The kinetic data in the malnourished stage were expressed per edema free body weight. Edema weight was estimated as the difference between body weight on the day of the malnourished stage experiment and the lowest postexperiment weight observed. During this period, all patients were offered a resuscitative diet that was estimated to maintain weight in normal children and not to promote growth. The actual intake (mean 6 SE) was 373 6 14 kJ × kg 21 × d 21 and ;1.07 6 0.04 g × kg 21 × d 21 of protein.
Statistical analysis. The results are presented as mean 6 SEM or as geometric mean (95% CI) if log-transformed. At admission to the hospital, a comparison of clinical characteristics between the 2 groups of children diagnosed with edematous and nonedematous SAM was performed using a nonpaired, 2-tailed t test. Comparison of anthropometric measurements and VLDL apo B-100 kinetics among the 3 stages of study was done by a 2-factor, repeated-measures ANOVA, with the between-group factor being diagnosis (edematous and nonedematous) and the stages of study being the repeated factor. Because of the nonnormal distribution of VLDL apo B-100 FSR and concentration, TG concentration, and the difference in variance between the 2 groups, the data were log-transformed before repeated-measures ANOVA was performed. If the interaction between diagnosis group and stage from the 2-factor, repeated-measures ANOVA was significant, then post hoc pairwise comparisons were performed by the Tukey test. The mean change from stage 1 to stage 2 and from stage 1 to stage 3 was compared between the edematous and the nonedematous groups using Wilcoxon's Signed Rank Sum test. Stata Statistical Software version 8 for Windows was used for the analysis. Results were considered significant if P , 0.05.
Results
There was no significant difference in age between the edematous and nonedematous groups. Wasting (weight-for-length) was greater in the nonedematous group than in the edematous group ( Table 1) . Weight and length increased from the initial study at stage 1 when severely malnourished to stage 2 at 50% weight repletion and to recovery at stage 3 (P , 0.0001) ( Table  1 ). Twenty of the 22 children had infections, each with 1-4 types of infections ( Table 2 ). The 2 children showing no signs of infection were edematous and nonedematous. On admission, hemoglobin and albumin concentrations and white blood cell counts were higher in the nonedematous compared with the edematous children ( Table 2) . Plateau isotopic enrichment of apo B-100-bound leucine was achieved in all the studies. The FSR and absolute rate of synthesis of VLDL apo B-100 did not differ between the edematous and nonedematous groups or from the initial severely malnourished stage to the recovered stage ( Table 3) . Changes in synthesis from stage 1 to stage 2 or 3 did not differ between the edematous and nonedematous groups (Fig. 1) . Concentrations of VLDL apo B-100 and TG were greater in the edematous group compared with the nonedematous group (P , 0.01) ( Table 3 ). The TG concentration increased from the acutely malnourished stage to the mid-catch-up and recovered stages.
Discussion
It is possible that synthesis of VLDL apo B-100 is impaired in childhood SAM, especially in the edematous syndromes, and that this contributes to the common occurrence of hepatic steatosis in this condition (3, 5) . Therefore, the aim of this study was to investigate if there was a difference in the rate of synthesis of VLDL apo B-100 in children with SAM compared with when they are nutritionally rehabilitated and well nourished, and to compare the synthesis rates between edematous and nonedematous SAM. The results showed no significant difference in the rate of synthesis between the edematous and nonedematous groups of children or from the initial severely malnourished state to the well-nourished state at recovery. These findings do not support indirect evidence that synthesis of VLDL apo B-100 is slower when children develop edematous SAM.
Seakins and Waterlow (2) observed that the incorporation of radiolabeled glycine and leucine into serum LDL and VLDL was slower when rats were fed a low-protein diet. This finding has been the main basis of the hypothesis that synthesis of the apoprotein moiety of VLDL apo B-100 is lower in children with SAM as a consequence of consuming diets low in protein and amino acids. This belief is not supported by the data of the present study indicating that the rate of synthesis of VLDL apo B-100 did not increase from the severely malnourished state to the recovered state. Because VLDL apo B-100 is necessary for the secretion of liver fat, it has been proposed that the prominent feature of fatty liver in children with SAM is due to diminished VLDL apo B-100 synthesis (3, 5) . Liver fat was not measured in this study. However, although fatty liver is generally more prevalent in edematous compared with nonedematous malnutrition, there was also no difference in the VLDL apo B-100 synthesis rate between these types of malnutrition. Despite no significant difference in VLDL apo B-100 synthesis rate, the concentrations of both VLDL apo B-100 and TG were significantly higher in the edematous children, suggesting that they might have had a slower rate of hydrolysis and clearance of VLDL from the circulation. This is consistent with data from a study by Agbedana et al. (14) showing lower postheparin serum lipase activity in children with edematous than in children with nonedematous SAM, which suggests that lipoprotein-TG hydrolysis may be slower in edematous than in nonedematous SAM. The concentration of TG but not of VLDL apo B-100 was lower when acutely malnourished compared with the mid-catch-up and recovered stages. Although concentrations of these 2 variables often change in the same direction, the kinetics of apo B-100 do not necessarily reflect those of TG, which is found in all plasma lipoproteins. The children received 5% glucose for 8 h for the kinetics measurements, but TG can remain above fasting condition for ;8 h or more after ingestion of fat-containing food as chylomicrons are removed from circulation (15) . The contribution of energy from fat was 20% for the acute phase treatment diet and 40.2% for the catch-up growth diet. Therefore, lower fat intake during the acute phase of treatment could contribute to the lower TG concentration.
Another factor that can modulate VLDL apo B-100 and TG kinetics in SAM is infection. All except 2 of the children had at least one type of infection. Hypertriacylglycerolemia that frequently accompanies infections may be associated with an enhanced hepatic production of VLDL apo B-100 (16) (17) (18) (19) (20) secondary to increased adipose tissue lipolysis and increased de novo hepatic fatty acid synthesis or with decreased VLDL apo B-100 clearance (16, 18) . The effect on VLDL apo B-100 production may depend on the degree and type of infection. Using bacterial LPS to mimic infection in rats, Feingold et al. (16) showed that low-dose LPS produces hypertriacylglycerolemia by increasing hepatic lipoprotein production, whereas high-dose LPS did not increase hepatic fatty acid synthesis, peripheral lipolysis, or hepatic TG secretion but produced hypertriacylglycerolemia by decreasing lipoprotein catabolism. It is therefore difficult to assess the impact of infection on VLDL apo B-100 synthesis in the present study because the degree of infection in the children is not clearly known and the overall effect is not fully understood. replacing 50% of their weight deficit; stage 3, when they had attained at least 90% of reference weight-for-height (recovery). ASR, absolute synthesis rate; FSR, fractional synthesis rate.
FIGURE 1
Changes in VLDL apo B-100 ASR in edematous and nonedematous groups of children from stage 1 when they were severely malnourished to stage 2 when they had replaced 50% of their weight deficit and to stage 3 when they had attained at least 90% of reference weight for length. Values are mean 6 SEM, n = 15 (edematous) or 7 (nonedematous). ASR, absolute synthesis rate.
In conclusion, the data from this study have not supported the belief that children with SAM, especially the edematous syndromes, have lower rates of VLDL apo B-100 synthesis compared with when they are well nourished. Therefore, it seems unlikely that the secretion of liver TG is reduced in children who develop SAM.
